WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 2701 Infant (under 12 months) mortality rate: 542
GDP / capita (US$): 7941 Child (under 5 years) mortality rate: 822

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 11'179  10'817  10'466  10'125  9'790  6'767  5'613  4'127 
Births 488  476  463  450  436  292  278  210 
Surviving infants 452  440  428  415  401  264  245  185 
Pop. less than 5 years 2'062  2'000  1'941  1'879  1'808  1'219  1'137  782 
Pop. less than 15 years 5'008  4'829  4'656  4'488  4'324  3'303  2'684  1'831 
Female 15-49 years 2'624  2'548  2'474  2'401  2'330  1'471  1'236  974 

Number of reported cases

(Click for retrospective incidence data for Burundi)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  49  129  18'363  13'282  49'227 
Mumps
ChartChart
 
Pertussis
ChartChart
  72  529  9'613 
Polio*
ChartChart
  10  43 
Rubella
ChartChart
  79  71  11  67 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  16  25 
Tetanus (total)**
ChartChart
  33  65  256 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Burundi)
Vaccine year result method % card seen                                                
BCG 2011  98  EPI   51  93  92  95  98  90  73  97 
DTP1 2011  99  EPI   51  97  98  98  98  99*  74 
DTP3 2011  98  EPI   51  94  95  96  96  99*  68  86 
DTP4         
IPV1          60 
HepB_BD         
HepB3 2011  98  EPI   51  94  95  96  96  99* 
Hib3 2011  98  EPI   51  94  95  96  96  99* 
JapEnc         
MCV1          93  94  98  93  99*  61  74 
MCV2          65  60  51 
PCV1          97  98  98  99*  31 
PCV3          94  95  96  99*  14 
Pol3 2011  98  EPI   51  94  95  96  96  99*  69  97 
Rota1          97  98  14 
RotaC          96  96 
Rubella1         
TT2plus 2009  32  DHS   62  90  80  96  88  99*  28  56 
PAB         
VAD1          15  27  27 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Burundi)
BCG
ChartChart
  93  92  95  98  90  85  97 
DTP1
ChartChart
  97  98  98  98  99  88  95 
DTP3
ChartChart
  94  95  96  96  96  80  86 
HepB3
ChartChart
  94  95  96  96  96 
HepB_BD
ChartChart
 
Hib3
ChartChart
  94  95  96  96  96 
IPV1
ChartChart
 
MCV1
ChartChart
  93  94  98  93  93  72  74 
MCV2
ChartChart
  65  60  51 
PAB
ChartChart
  85  85  85  85  80  51  67 
PCV3
ChartChart
  94  95  96  96  14 
Pol3
ChartChart
  94  95  96  96  95  71  97 
RCV1
ChartChart
 
RotaC
ChartChart
  96  96 
YFV
ChartChart
 

Number of districts in the country 45  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 71
From 80 to 89% 18
From 50 to 79% 11
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; Yes From March 2016
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV No From April 2016
IPV 14 weeks; Yes
MR 9, 18 months; Yes From November 2016
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 16 weeks; Yes
Rotavirus 6, 10 weeks; Yes
Td 1st contact; +1,+6 months; +1, +1 year; Yes
VitaminA 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2011-2015  2010-2014  2010-2014 
Nº of districts with microplans that include activities to raise immunization coverage number 45  45  45  45  45  45  45 

System performance

Total Nº districts in country number 45  45  45  45  45  45  43 
Nº districts with DTP3 coverage >=80% number 40  38  42  42  44  41  39 
% of districts with DTP3 coverage >=80% From 0 to 100% 89  84  93  93  98  91  91 
Nº districts with measles (MCV1) coverage >=95% number 18  20  27  31  29  16  24 
% of districts with MCV1 coverage >=95% From 0 to 100% 40  44  60  69  64  36  56 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%     10  22 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.